Deutsche Bank
WHWK

Deutsche Bank’s Whitehawk Therapeutics WHWK Stock Holding History

Deutsche Bank’s Portfolio WHWK Stock Details WHWK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-12,268
Closed -$59.4K – 3725
2023
Q3 		$59.4K Hold
12,268
– – ﹤0.01% 3361
2023
Q2 		$83.9K Buy
12,268
+2,887
+31% +$22.4K ﹤0.01% 3347
2023
Q1 		$67.9K Buy
9,381
+2,973
+46% +$31.8K ﹤0.01% 3468
2022
Q4 		$82.2K Buy
6,408
+96
+2% +$1.25K ﹤0.01% 3419
2022
Q3 		$89K Sell
6,312
-971
-13% -$12.8K ﹤0.01% 3383
2022
Q2 		$89K Buy
+7,283
New +$108K ﹤0.01% 3572
2020
Q1 		– Sell
-447
Closed -$4K – 4909
2019
Q4 		$4K Buy
+447
New +$3.73K ﹤0.01% 4715

Other funds holding WHWK

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
AIM
Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Deutsche Bank's WHWK Position: Q4 2023 in Review

Deutsche Bank sold out of Whitehawk Therapeutics (WHWK) in Q4 2023, closing a stake of 12,268 shares — an estimated $59.4K sold.

Deutsche Bank first reported a position in WHWK in Q4 2019 and held it in 7 quarters. The position peaked at $89K in Q3 2022. 65 funds tracked by Wall St. Rank hold WHWK as of Q4 2023.

  • Deutsche Bank reported no remaining Whitehawk Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Deutsche Bank sold 12,268 Whitehawk Therapeutics shares in Q4 2023, an estimated $59.4K.
  • Deutsche Bank first reported a position in Whitehawk Therapeutics in Q4 2019 and held it in 7 quarters.
  • Deutsche Bank's Whitehawk Therapeutics position peaked at $89K in Q3 2022.
  • 65 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q4 2023.

Based on Deutsche Bank's 13F filing for Q4 2023, filed 14 Feb 2024.